Condition: Oligoarthritis, Juvenile · Polyarthritis, Juvenile, Rheumatoid Factor Negative · Sponsor: Istituto Giannina Gaslini
This study aims to compare the effectiveness of a conventional therapeutic regimen, based on treatment escalation (step-up strategy) and driven by the treat-to-target approach, with that of an early aggressive intervention based on the initial start of a combination of conventional and biological DMARDs (step-down strategy).
This description comes directly from the study's public registry record.
Alessandro Consolaro, MD, PhD · 01056362729 · alessandroconsolaro@gaslini.org
Always discuss trial participation with your own doctor first.
| IRCCS Istituto Giannina Gaslini | Genova, GE, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03728478